Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition
Launched by TRI-SERVICE GENERAL HOSPITAL · Aug 25, 2023
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a type of therapy called Cognitive Behavioral Therapy for Insomnia (CBT-I) on nurses who are experiencing ongoing health issues after recovering from COVID-19. Many nurses have reported problems like trouble sleeping, anxiety, depression, and pain after their illness. While medications can help, they may lead to issues with dependency. This study aims to see if CBT-I can improve these symptoms without the risks associated with medication.
To participate, nurses who have these post-COVID-19 conditions can join the trial, as long as they do not have certain sleep disorders or other specific health issues. In the study, 100 nurses will be randomly divided into two groups: one receiving CBT-I and the other receiving standard care. The therapy will last for six weeks, and researchers will check in with participants over the next three months to see how their sleep, mood, and overall health change. This trial could be important for finding safer ways to help nurses recover from the challenges they face after COVID-19.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • nurses with post COVID-19 condition
- Exclusion Criteria:
- • history of sleep apnea, narcolepsy, pregnant, seizure, with pacemaker
About Tri Service General Hospital
The Tri-Service General Hospital (TSGH) is a leading medical institution in Taiwan, dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent military hospital, TSGH integrates cutting-edge medical practices with rigorous scientific inquiry, fostering a collaborative environment for healthcare professionals and researchers. The hospital is committed to enhancing treatment outcomes and improving public health by conducting a diverse range of clinical trials across various medical specialties, ensuring adherence to the highest ethical standards and regulatory guidelines. Through its research initiatives, TSGH aims to contribute significantly to the global medical community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported